On the intrinsic moisture permeation rate of remote microwave plasma-deposited silicon nitride layers

We report on a low substrate temperature (110 °C) remote microwave plasma-enhanced chemical vapor deposition (PECVD) process of silicon nitride barrier layers against moisture permeation for organic light emitting diodes (OLEDs) and other moisture sensitive devices such as organic photovoltaic cells (OPVs). Specifically, the influence of the SiH4/NH3 gas flow ratio on the layer composition and intrinsic moisture barrier performance is investigated, as inferred from Fourier Transform Infrared (FTIR) spectroscopy, Rutherford Back Scattering (RBS) analysis, and the calcium test. Since the presence of extrinsic factors for barrier failure such as pinholes and contamination particles (defects) is largely determined by the substrate conditioning and environment, the focus in this research is on the intrinsic permeability of the silicon nitride films, as measured by monitoring the homogeneous degradation of defect (e.g. pinholes and contamination particles)-free calcium regions. The investigated films have tunable chemical composition and optical properties and moderate residual strain levels varying from tensile to compressive. Despite this variation in film properties, the intrinsic water vapor transmission rate (WVTR) is found to be constant at a level of 1 · 10- 5 g/m2 day at 20 °C/50%RH conditions for films deposited at 0.1–0.5 nm/s. When the total gas flow rate is increased in order to achieve higher growth rate processing (0.2–1.0 nm/s), a higher permeability is measured at increased SiH4/NH3 ratio. The development of high surface roughness in the silicon nitride layer, as shown by AFM analysis, suggests cluster/dust formation in the plasma and powder inclusion during film deposition. This eventually leads to higher water vapor transmission rate of the deposited layers

Essaybundel RWS Imagine!: hoe kan die nieuwe wereld van big data, veranderde mobiliteit, transformatie van netwerken en duurzame leefomgeving er fysiek uitzien?

In juni 2014 heeft het Bestuur van Rijkswaterstaat aan het Programma Strategische Verkenningen gevraagd een designsessie te organiseren voor de Groepsraad van Rijkswaterstaat. De designsessie moet antwoord geven op de vraag: ‘hoe kan die nieuwe wereld van big data, veranderende mobiliteit, transformatie van de netwerken en een duurzame leefomgeving er fysiek uit zien? En hoe werken we samen in die nieuwe wereld?’ Ter voorbereiding van deze sessie is aan 10 personen, met verschillende expertises, gevraagd een essay te schrijven. Martijn de Waal (onderzoeker Citizen Empowerment aan de HvA) leverde een bijdrage

The Probability of Metastases Within Different Prostate-specific Antigen Ranges Using Prostate-specific Membrane Antigen Positron Emission Tomography in Patients with Newly Diagnosed Prostate Cancer

Background and objectives: The association between prostate-specific antigen (PSA) level and probability of metastatic disease on prostate-specific membrane antigen (PSMA) positron emission tomography/computed tomography (PET/CT) has not yet been established in patients with newly diagnosed prostate cancer (PCa). Our objective was to assess the probability of metastatic disease within different PSA ranges using PSMA PET/CT for initial staging of PCa, and to identify both the anatomical distribution and the predictors of metastases on PSMA PET/CT. Methods: In total, 2193 patients with newly diagnosed PCa were retrospectively studied. PSMA PET/CT was performed for staging purposes between January 2017 and May 2022. The proportion of patients with PSMA-avid metastases, stratified by PSA level, was studied. A vast majority of patients in whom at least one high-risk prognostic factor was present underwent PSMA PET/CT. A multivariable logistic regression analysis was performed to identify the predictors of metastases on PSMA PET/CT using clinical, biochemical, radiological, and pathological variables. Key findings and limitations: The median PSA level at PSMA PET/CT was 14.1 ng/ml. Any metastatic disease (miN1-M1a-c) was observed in 34.7% (763/2193) of all patients and distant metastases (miM1a-c) in 25.4% (557/2193) of patients. The presence of any metastatic disease increased with PSA levels, being 15.4% in men with PSA levels 100 ng/ml. The multivariable logistic regression analysis found significant associations between the presence of any metastatic disease and PSA subgroups, clinical tumor stage ≥T2, grade group >3, and radiological tumor stage ≥T3b. Conclusions and clinical implications: This is the first large epidemiological study in patients with PCa demonstrating the association between PSA subgroups and metastatic disease on modern imaging PSMA PET/CT. Data from this study can be used to counsel patients on the probability of metastatic disease at the time of PSA screening and to provide guidance on existing guidelines. Patient summary: The prostate-specific antigen level could be used to assess the risk of metastases on prostate-specific membrane antigen positron (PSMA) emission tomography/computed tomography (PET/CT). This knowledge is valuable for selecting patients who will benefit most from metastatic screening with PSMA PET/CT